Quick Read
A biotech pitch deck is a short slide presentation that explains your science, proof, market, regulatory plan, and funding need to investors. Most strong decks run 12 to 15 main slides, lead with the unmet medical need, show data in simple charts, and end with a clear ask. Fix jargon, vague use of funds, and a missing regulatory plan first. Those three problems sink more decks than weak science does.
Introduction
You spent years on your research. The data is real. The science could help patients. Then you send your deck to an investor, and you hear nothing back.
It happens a lot. Investors read hundreds of decks a year, and many founders pack too much data on each slide. The science is strong, but the story is hard to follow.
This guide shows you how to do that. You will learn who reads your deck, which 10 slides to include, how to explain complex science, and which mistakes to avoid.
What Is a Biotech Pitch Deck, and How Is It Different from a Standard Startup Deck?
A biotech pitch deck is a slide presentation, usually 12 to 20 slides, that makes the case for funding a life sciences company. It covers the medical problem, your solution, early evidence, your development plan, the market, the team, and the ask.
The purpose is simple. You want the reader to say, “I need to hear more.”
Why biotech investors evaluate differently
A software startup can launch in months and learn from users right away. Biotech works on a different clock. Investors know a few things going in:
- Timelines are long. Moving a drug from lab to approval often takes 10 years or more.
- Regulatory risk is high. Fewer than 1 in 10 drugs that enter human trials reach approval.
- Capital needs are large. Trials cost millions, and the bill grows at each phase.
Because of that, investors do not just ask, “Is the idea good?” They ask, “Will this company reach its next milestone before the money runs out?” Your deck must answer that question clearly.
Who reads your deck
Different readers look for different things:
- Venture capital firms want a large return and a clear exit path.
- Angel investors often back early science and a strong founder.
- Pharma partners look for assets that fit their pipeline.
- Grant bodies want scientific merit and public benefit.
Knowing your reader shapes every slide. The next section shows how.
Know Your Investor Before You Build the Deck
Many founders build one deck and send it everywhere. That rarely works. Spend an hour on research first. You will save weeks of rewrites.
If you search for a pitch deck biotech example online, you will find plenty of slides. Few of them tell you who the deck was built for. That context matters as much as the layout.
Seed vs. Series A vs. later-stage expectations
Each stage asks for different proof.
| Stage | What investors want to see |
|---|---|
| Seed | A strong scientific idea, early lab data, a credible team, and a clear target |
| Series A | Solid preclinical data, a defined clinical plan, and early regulatory input |
| Series B and later | Human data, a clear path to the next trial phase, and a manufacturing plan |
At seed stage, you sell the science and the team. By Series A, you sell the data and the plan. Match your slides to the stage you are raising.
Specialist life sciences VCs vs. generalist funds
Specialist life sciences funds have scientists on staff. They will ask about your assay design, your endpoints, and your trial plan. You can go deep on the data.
Generalist funds are different. They may have no science background, so they care more about market size and story. For them, simplify the mechanism and lead with the patient need.
Strategic partners and non-dilutive funding
Not all money costs you equity. Non-dilutive funding includes government grants, such as SBIR and STTR awards in the US, along with foundation grants and accelerator programs. Pharma companies may also fund early work through research deals.
This capital can facilitate your progression toward a more substantial objective prior to equity divestment. Mention it in your deck if you have it or plan to apply.
10 Essential Slides Every Biotech Pitch Deck Needs
The biotech pitch deck essential elements are the same across most successful raises. You can adjust the depth, but each of the 10 slides below answers a question an investor will ask.
1. Title and Vision Slide: one-line company mission
Keep this slide clean. Add your company name, logo, and one sentence about what you do. For example: “We are developing an oral therapy that slows kidney damage in diabetic patients.”
Skip long taglines. A plain sentence beats a clever one.
2. The Problem and Unmet Medical Need: patient burden, current standard of care gaps
Start with the patient, not the molecule. Show how many people live with the condition, what it costs them, and where current treatments fall short.
Use one or two strong numbers. Then show the gap. If today’s drug works for only half of patients, say so.
3. The Solution and Mechanism of Action: explain the science simply
Explain what your therapy does and how it works. Use one clean diagram that shows the target, the action, and the result.
Test it on a friend outside science. If they're able to repeat it back to you, then you're all set.
4. Preclinical and Clinical Data: proof points, key figures, validation
Show your best evidence first. Pick two or three key results and make each one easy to read. Label the axes, state the sample size, and add one line that says what the result means.
Put extra charts in the appendix. Be honest about limits too. Investors trust founders who name weak spots before they are asked.
5. Pipeline and Development Roadmap: milestones by phase
Show a simple timeline. Identify the discovery phase, then track through IND filing, and finally mark out the clinical trial phases. Add the key milestones you will reach and when.
A pipeline bar chart works well here. Highlight your lead program so the eye lands in the right place.
6. Market Opportunity: TAM, SAM, SOM and patient population
Size the market in three layers:
- TAM (total addressable market): everyone who could use a therapy like yours
- SAM (serviceable addressable market): the patients your drug can treat
- SOM (serviceable obtainable market): the share you can realistically win
Start from patient numbers and expected pricing. Avoid the “1% of a huge market” shortcut. Investors have seen it too many times.
7. Regulatory and Reimbursement Strategy: FDA/EMA pathway, designations
Explain how you will get approved and paid for. Name your path, such as an IND followed by Phase 1 to 3 trials, or a faster route if one applies.
List any designations you have or plan to seek, such as Orphan Drug, Fast Track, or Breakthrough Therapy. Add a line on how payers will view your drug. Approval without reimbursement does not build a business.
8. IP and Competitive Landscape: patents, freedom to operate, differentiation
Show what you own and why it holds up. List your patents, filing dates, and expiry. Mention your freedom to operate status, which tells investors that no one else’s patents block your path.
Then show where you stand against rivals. A competitor analysis pitch deck slide works best as a simple table or 2x2 grid. List three to five competitors and compare them on the points that matter, such as efficacy, safety, dosing, and stage. Be fair. Then show why you're still the better choice overall.
9. Team and Advisors: scientific credibility and execution track record
Investors back people first. Show each leader’s photo, role, and one proof point, such as “led two IND filings” or “published in Nature.”
Add advisors who fill gaps. A clinical advisor or a former FDA reviewer adds real weight. Flag any open hires and say when you will fill them.
10. The Ask and Use of Funds: raise amount, runway, milestones unlocked
End with a clear ask. State how much you are raising, what the money will buy, and how long it lasts.
A simple pie chart or bar split helps, for example, 55% on clinical work, 25% on manufacturing, and 20% on operations. Then name the milestones the round unlocks, such as “IND clearance in 14 months.”
Put these 10 slides in this order, and you have an Ideal investor pitch deck for most early-stage raises. The story moves from need, to solution, to proof, to plan, to ask.
Ready to Take Your Pitch Deck to the Next Level?
If you found this guide helpful, imagine what we can do for your actual deck.
How to Present Complex Science Without Losing Investors
Your science is your edge. It can also be your biggest barrier. A reader who gets lost in slide three will not make it to slide ten.
Simplify the mechanism: analogies and visuals
Use an analogy to anchor the idea. For instance, you might describe a drug as “a key that fits only the broken lock.” Then back it up with a simple visual. Keep jargon to a minimum. When you must use a technical term, define it in a few words the first time.
Data visualization rules for clinical results
Good charts make data easy to trust. Follow these rules:
- Show one message per chart.
- Label axes and units clearly.
- Mark statistical significance in plain terms.
- Use color purposefully, for example, one color for your drug and gray for the control.
- Remove gridlines, extra legends, and decoration.
Strong presentation design helps investors see the result in five seconds. If they must decode the chart, the slide has failed.
Slide-by-slide word count and design guidelines
Use these guardrails as a starting point:
- Words per slide: 30 to 50 on a presented deck, up to 100 on a deck sent by email
- Font size: 18 points or larger for body text
- Visuals: one main visual per slide
- Headline: a full sentence that states the takeaway, such as “Our drug cut tumor growth by 60%.”
A headline that states the point does half the work for you.
Step-by-Step: How to Build a Biotech Pitch Deck
Here is a simple process you can follow from blank page to final file.
Step 1: Define your core narrative and milestone story
Before opening any slides, summarize the story in three sentences. Cover the patient problem, your solution, and the milestone this round will reach.
Every slide should support that story. If it does not, cut it.
Step 2: Map slides to investor questions
List the questions an investor will ask, then match each to a slide. Common ones include:
- Is the problem big enough?
- Does the science work?
- Can you get approved?
- Can you protect it?
- Can this team deliver?
If a question has no home, add a slide or a line. If a slide answers no question, drop it.
Step 3: Draft, design, and stress-test
Start with the words. Strong pitch deck writing is short and direct. Use plain verbs, one idea per slide, and numbers over adjectives. Next, add the design. Keep a clean grid, a limited color palette, and consistent fonts. Then stress-test. Show the deck to a scientist, a non-scientist, and someone who has raised money. Ask each what they remember. Fix whatever they miss.
Step 4: Prepare the appendix and Q&A backup slides
Build backup slides for the questions you expect. Good candidates include extra data, manufacturing details, trial design, a detailed financial model, and the full IP table. Keep your main deck lean and focused-aim for somewhere between 12 to 15 slides total. The appendix holds the depth. When an investor asks a hard question, you can pull up the answer in seconds.
Common Biotech Pitch Deck Mistakes (and How to Fix Them)
Investors scan decks fast, and certain Red flags in pitch decks make them stop reading. Here are the five that show up most, along with the fix for each.
Too much jargon and data density
The problem: Slides packed with terms and tiny charts.
The fix: Show one result per slide, define terms, and move extra data to the appendix.
Weak or missing regulatory strategy
The problem: No plan for how you will get approved.
The fix: Name your pathway, your next filing, and any designations you will pursue. Show you have talked to regulators, or plan to.
Overstated market size
The problem: A huge number with no patient math to back it up.
The fix: Build the market from patient counts, eligible groups, and realistic pricing.
Vague use of funds
The problem: “R&D and general costs” with no detail.
The fix: Split the money by activity and tie it to milestones and months of runway.
Ignoring the competitive landscape
The problem: Someone's saying "nobody else pulls off this move."
The fix: Show real competitors, including big pharma programs, and explain your edge in specific terms.
Should You Hire a Pitch Deck Design Partner?
Doing it yourself can work if you have early traction, a short deck, and time to test it. Many seed founders start this way.
Expert help pays off when the stakes rise. That includes a Series A raise, a pharma partnership pitch, a conference slot, or a deck that keeps getting no replies. If you have the science but cannot find the story, pitch deck consulting can shape the narrative, tighten the data, and prepare you for tough questions.
Choose a partner who checks three boxes:
- Science fluency: They get what you're talking about in your field, or they pick it up pretty quickly. You should not have to explain what an IND is.
- Investor-grade design: Their slides look sharp, and the charts are clear and accurate.
- Storytelling: They can turn your data into a clear arc with a strong ask.
Ask to see past life sciences work. Then ask how they handle feedback from your scientists. The best partners actually team up with your crew instead of going off on their own.
Final Thoughts
A strong biotech pitch deck does not try to show everything. It shows the right things, in the right order, in plain words. Start with the patient problem rather than the molecule, and match your deck to your investor and funding stage. Build on the 10 essential slides as your base structure, and keep each slide to one message and one visual. Fix the common mistakes before investors spot them, and save your depth for the appendix.
Your science took years to build. Give it a deck that does it justice. Want a second set of eyes on your deck? Book a free pitch deck review and get clear, practical feedback on your story, data, and design.
Frequently Asked Questions
1. What makes a good biotech pitch deck?
A good biotech pitch deck tells a clear story in plain words. It opens with a real unmet medical need, shows credible data, lays out a path to approval, and ends with a specific ask. It is easy to scan, and each slide makes one point.
2. How many slides should a biotech pitch deck have?
Most biotech pitch decks have 12 to 15 main slides, plus an appendix. The 10 essential slides in this guide form the core. Add a few for extra detail, such as a financial snapshot or partnership plans, if your stage calls for them.
3. What do biotech investors look for in a pitch deck?
Investors look for five things: a large unmet need, strong scientific proof, a clear regulatory path, protected IP, and a team that can deliver. They also want to know what milestone the funding will reach.
4. How long should a biotech pitch presentation be?
Plan for 15 to 20 minutes of presenting, with extra time for questions. A 12 to 15 slide deck fits that window. Spend more time on the problem, data, and ask, and less on background.
5. Do I need clinical data to pitch a biotech startup?
No. Early-stage founders often raise on preclinical data, a strong scientific rationale, and a solid team. Clinical data helps at later stages. If you do not have it yet, show your plan and the milestones that will produce it.
6. What is the best format for a biotech investor presentation?
Use a slide deck in 16:9 format, saved as a PDF for email and as a slide file for live pitches. Keep a short version to send first and a longer version with the appendix for follow-up meetings.
